Cleared Traditional

K894973 - RESPITRACE PLUS

K894973 is an FDA 510(k) clearance for RESPITRACE PLUS, manufactured by Hogan & Hartson. The device is a Class 2 Anesthesiology device with product code FLS cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K894973 · Hogan & Hartson · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1989
Decision
84d
Days
Class 2
Risk

K894973 is an FDA 510(k) clearance for the RESPITRACE PLUS. Classified as Monitor, Apnea, Facility Use (product code FLS), Class II - Special Controls.

Submitted by Hogan & Hartson (Washington, D.C., US). The FDA issued a Cleared decision on October 30, 1989 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2377 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hogan & Hartson devices

FDA 510(k) Submission Details - K894973

510(k) Number K894973 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 1989
Decision Date October 30, 1989
Days to Decision 84 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 140d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FLS Device Classification - Class 2, Special Controls

Product Code FLS Monitor, Apnea, Facility Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2377
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - FLS Monitor, Apnea, Facility Use

All 7
Devices cleared under the same product code (FLS) and FDA review panel - the closest regulatory comparables to K894973.
HANNAH WIRELESS VITAL SIGNS MONITOR
K991087 · Ilife Systems, Inc. · Jan 2000
REMBRANDT SYSTEM
K962865 · Airsep Corp. · Oct 1996
PROPAQ ENCORE 200 SERIES MONITOR WITH NEONATAL MODE AND IMPEDANCE PNEUMOGRAPHY OPTIONS
K951246 · Protocol Systems, Inc. · Feb 1996
RESPIRATION MONITOR
K832999 · Litton Medical Electronics · Feb 1984
CLINICAL DATA APNEA DETECTOR
K821721 · Clinical Data, Inc. · Jul 1982
INFUSION CONTROLLER, PARENTERAL
K781216 · National Patent Development Corp. · Aug 1978